191 related articles for article (PubMed ID: 22750521)
1. Motor terminal degeneration unaffected by activity changes in SOD1(G93A) mice; a possible role for glycolysis.
Carrasco DI; Bichler EK; Rich MM; Wang X; Seburn KL; Pinter MJ
Neurobiol Dis; 2012 Oct; 48(1):132-40. PubMed ID: 22750521
[TBL] [Abstract][Full Text] [Related]
2. Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Carrasco DI; Seburn KL; Pinter MJ
Exp Neurol; 2016 Jan; 275 Pt 1(0 1):172-81. PubMed ID: 26416261
[TBL] [Abstract][Full Text] [Related]
3. Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.
Carrasco DI; Bahr BA; Seburn KL; Pinter MJ
Exp Neurol; 2016 Apr; 278():116-26. PubMed ID: 26853136
[TBL] [Abstract][Full Text] [Related]
4. Axonal and neuromuscular synaptic phenotypes in Wld(S), SOD1(G93A) and ostes mutant mice identified by fiber-optic confocal microendoscopy.
Wong F; Fan L; Wells S; Hartley R; Mackenzie FE; Oyebode O; Brown R; Thomson D; Coleman MP; Blanco G; Ribchester RR
Mol Cell Neurosci; 2009 Dec; 42(4):296-307. PubMed ID: 19683573
[TBL] [Abstract][Full Text] [Related]
5. Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice.
Carrasco DI; Bichler EK; Seburn KL; Pinter MJ
PLoS One; 2010 Mar; 5(3):e9802. PubMed ID: 20339550
[TBL] [Abstract][Full Text] [Related]
6. Functional over-load saves motor units in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Gordon T; Tyreman N; Li S; Putman CT; Hegedus J
Neurobiol Dis; 2010 Feb; 37(2):412-22. PubMed ID: 19879358
[TBL] [Abstract][Full Text] [Related]
7. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
[TBL] [Abstract][Full Text] [Related]
8. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease.
De Winter F; Vo T; Stam FJ; Wisman LA; Bär PR; Niclou SP; van Muiswinkel FL; Verhaagen J
Mol Cell Neurosci; 2006; 32(1-2):102-17. PubMed ID: 16677822
[TBL] [Abstract][Full Text] [Related]
9. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
Gould TW; Buss RR; Vinsant S; Prevette D; Sun W; Knudson CM; Milligan CE; Oppenheim RW
J Neurosci; 2006 Aug; 26(34):8774-86. PubMed ID: 16928866
[TBL] [Abstract][Full Text] [Related]
10. Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1(G93A) mice.
Pardo AC; Wong V; Benson LM; Dykes M; Tanaka K; Rothstein JD; Maragakis NJ
Exp Neurol; 2006 Sep; 201(1):120-30. PubMed ID: 16753145
[TBL] [Abstract][Full Text] [Related]
11. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice.
David G; Nguyen K; Barrett EF
Exp Neurol; 2007 Mar; 204(1):411-20. PubMed ID: 17292357
[TBL] [Abstract][Full Text] [Related]
12. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.
Vande Velde C; Garcia ML; Yin X; Trapp BD; Cleveland DW
Neuromolecular Med; 2004; 5(3):193-203. PubMed ID: 15626820
[TBL] [Abstract][Full Text] [Related]
13. Neuron-specific expression of CuZnSOD prevents the loss of muscle mass and function that occurs in homozygous CuZnSOD-knockout mice.
Sakellariou GK; Davis CS; Shi Y; Ivannikov MV; Zhang Y; Vasilaki A; Macleod GT; Richardson A; Van Remmen H; Jackson MJ; McArdle A; Brooks SV
FASEB J; 2014 Apr; 28(4):1666-81. PubMed ID: 24378874
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
[TBL] [Abstract][Full Text] [Related]
15. The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.
Zhai J; Zhou W; Li J; Hayworth CR; Zhang L; Misawa H; Klein R; Scherer SS; Balice-Gordon RJ; Kalb RG
Hum Mol Genet; 2011 Nov; 20(21):4116-31. PubMed ID: 21816949
[TBL] [Abstract][Full Text] [Related]
16. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
17. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular effects of G93A-SOD1 expression in zebrafish.
Sakowski SA; Lunn JS; Busta AS; Oh SS; Zamora-Berridi G; Palmer M; Rosenberg AA; Philip SG; Dowling JJ; Feldman EL
Mol Neurodegener; 2012 Aug; 7():44. PubMed ID: 22938571
[TBL] [Abstract][Full Text] [Related]
20. Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminal.
Hayes LR; Asress SA; Li Y; Galkin A; Stepanova A; Kawamata H; Manfredi G; Glass JD
Exp Neurol; 2019 Aug; 318():251-257. PubMed ID: 31082391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
